Australia markets closed
  • ALL ORDS

    6,865.30
    +18.00 (+0.26%)
     
  • ASX 200

    6,634.10
    +18.80 (+0.28%)
     
  • AUD/USD

    0.7431
    -0.0009 (-0.12%)
     
  • OIL

    46.48
    +0.84 (+1.84%)
     
  • GOLD

    1,843.60
    +2.50 (+0.14%)
     
  • BTC-AUD

    25,920.69
    +23.57 (+0.09%)
     
  • CMC Crypto 200

    378.25
    +3.85 (+1.03%)
     
  • AUD/EUR

    0.6112
    -0.0010 (-0.16%)
     
  • AUD/NZD

    1.0511
    +0.0000 (+0.00%)
     
  • NZX 50

    12,631.38
    -17.53 (-0.14%)
     
  • NASDAQ

    12,467.13
    +10.72 (+0.09%)
     
  • FTSE

    6,490.27
    +26.88 (+0.42%)
     
  • Dow Jones

    29,969.52
    +85.73 (+0.29%)
     
  • DAX

    13,252.86
    -60.34 (-0.45%)
     
  • Hang Seng

    26,796.33
    +67.83 (+0.25%)
     
  • NIKKEI 225

    26,766.69
    -42.68 (-0.16%)
     

Anatara Lifesciences Ltd (ANR.AX) Investor Presentation

·1-min read
Anatara Lifesciences Ltd
Anatara Lifesciences Ltd

Anatara Lifesciences Ltd (ANR.AX) Investor Presentation

Melbourne, Australia, Oct 29, 2020 - (ABN Newswire) - Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at AusBiotech +Invest 2020.

To view the presentation, please visit:
https://abnnewswire.net/lnk/1NIGQC4U


About Anatara Lifesciences Ltd:


Anatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

Contact:

Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: slydeamore@anatara.com

Sue MacLeman
Chair
Anatara Lifesciences Ltd
T: +61-437-211-200
E: smacleman@anatara.com

Source:
Anatara Lifesciences Ltd

Copyright (C) 2020 ABN Newswire. All rights reserved.